Please login to the form below

Improve clinical trials through patient journey mapping

Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s time to look at the finer details and start improving every stage of the patient journey.

Have you ever really wanted to do something, or go somewhere, but the process of actually doing it is so complex that it just doesn’t seem worth it in the end? Yep. That could be how your patients are feeling.

Your patients might fully intend on joining a clinical study, but the process of even getting through the recruitment stage can make the idea of participating just not seem worthwhile. And we need to do something about it. Imagine this: a patient has heard about a clinical study that could potentially improve their life. They’re not 100% sure about taking part, but they’d like more information, so they…

  • Look online – but they can only seem to find information on for more information, which only provides a complex, science-heavy explanation with really bad UX
  • Find the clinical study website – the information is more understandable, but often doesn’t have contact details for more information, only the research site and postcode
  • Make a call – but end up communicating with call centres with inexperienced people, or people who are not from a medical background
  • Send an email – but the investigator working on the clinical study is too busy, so they get a delayed/no response

It’s time to make a change. During the last 10 years, clinical study designs and procedures have become increasingly complicated, not only demanding more staff time and effort, but unintentionally discouraging patient enrolment and retention. We get it, the clinical study process is complex, but it doesn’t have to be that way for patients.

So, what can we do about it?

Recognising that each participant has their own journey can have a huge influence on their experience, and consequently affect how likely they are to take part – or continue taking part – in a clinical study. And that’s where patient journey mapping comes in.

You might ask, “what exactly is patient journey mapping?” Well, it’s an exercise that allows you to better understand your patients experiences throughout their care journey. That means understanding every. single. step. of their journey – from initial diagnosis, to coming to terms with their treatment options, to the clinical study recruitment stage, to participating in the study, to clinical study completion, all the way to the follow-up process. How do things change from one stage to the next? Not just in terms of their clinical experience, but their psychological experience and emotional journey too? It’s important to understand these changes to identify the best way to engage and interact with your patients, and ultimately making things easier for them.

Consider a process mapping tool

Using process mapping tools and workshops enables everyone involved in the clinical study to see the overall picture. Looking at it this way allows everyone to understand exactly how complicated the journey can be for patients. And while this might be overwhelming at first, by breaking the process down into the different stages – you can identify opportunities where things can improve. Ask questions, such as “where are the longest delays occurring?” and “are there things that are done more than once?” This way, you can make corrections, improvements and avoid any unnecessary steps to make the patient journey easier.

There’s no better time than now to make a change

Patient journey mapping, especially when done earlier on in the clinical study planning stages, can improve your patients’ experiences and ultimately improve clinical study outcomes. If you’re looking for support to help map your patient journey, take a look at this handy checklist that we’ve put together to help.

Blog was originally published here.

22nd September 2020



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

COUCH Health publishes report to encourage patient engagement in the MedTech sector
Manchester, UK, 27 February 2023 — COUCH Health today announced the publication of a new report “The Power of Patient Engagement in MedTech”.
COUCH Health
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
In our recent Demand Diversity research, a Black American participant said, “I wish people were more educated. Doctors are supposed to treat everyone the same, not have favourites. They need unconscious bias training.”
COUCH Health
How do ethnic minority groups in the U.S. view clinical trials?
This year, we decided to do the same with ethnic minority communities over in the United States (U.S.) too. Ultimately, we wanted to explore attitudes towards clinical trials from these communities, understand the barriers in participation, and determine what factors may influence people’s decisions to take part.
COUCH Health
Three things to consider when using social listening research for patient recruitment
We are looking at how patient research can power your patient recruitment campaign. A look into social listening follows on from this blog perfectly, offering a stronger and more authentic alternative to relying on data trends to guide your activities. So, let’s get started…
COUCH Health
4 ways mobile ethnography studies can elevate your patient insights
How can we achieve more real-life, in-the-moment insights from different groups to understand their thoughts and behaviours? This is where ethnography studies come in.
COUCH Health
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. By now, you might think we sound a bit like a broken record. But, the fact is, many people still aren’t aware of the underrepresentation, especially those who don’t work in the industry. Do you think if the clinical research industry could see the people they were leaving out of clinical trials, and hear how they felt about being underrepresented, it would make a difference?
COUCH Health